INAB Research and Charts

INAB - IN8bio Inc Ordinary Shares (Healthcare: Biotechnology)

Projected Earnings Date: 0000-02-29 (Delayed quote data 2025-07-11)

Last 2.31	Change ⇑ +0.02 (+0.87%)	Volume 130,533
	Open 2.28	High 2.32	Low 2.21

8EMA (Daily) 2.27	40EMA (Daily) 3.01	50EMA (Daily) 3.31	STO (Daily) 55.964	MACD Hist (Daily) 0.198
8EMA (Weekly) 2.818	40EMA (Weekly) 7.85	50EMA (Weekly) 9.91	STO (Weekly) 5.459	MACD Hist (Weekly) 0.253


Company Profile
IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.